- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
New Book Offers "Practical Solutions" to Big Pharma Woes
A new book by Hedley Rees tackles a litany of pharma industry problems, including “eye-watering drug prices, shortages, litigation over damaging side effects, questionable marketing practices, economic adulteration, consent decrees, counterfeiting, patent games [and] price gouging”.
Rees says we should stop believing that medicines are different to all other products on sale in the market, because they are not. Science is an important component in bringing a medicine to the world, but it takes a healthy dose of engineering skills to get them there too, and the application of those skills is sadly lacking in pharma. The system for producing and supplying a medicine to market should be no different, he says, to an aero-engine, automobile or silicon chip. While the book is “uncompromising on facts and evidence”, it aims to offer a “practical solution” for the pharma industry, says the author. Taming The Big Pharma Monster by Speaking Truth to Power by Hedley Rees is published by Filament (London) on May 28, 2019. More information can be found at the author's website: pharmaflowltd.com
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
